Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Protein kinase C delta (PKCδ), encoded by PRKCD (HGNC:9399), is a novel protein kinase critical for B-cell tolerance and apoptosis. Common variable immunodeficiency (CVID) (MONDO:0015517) manifests with hypogammaglobulinemia, recurrent infections, and impaired vaccine responses, and <20% of CVID cases have a defined monogenic etiology. Recent genomic studies and case reports implicate autosomal recessive PRKCD loss-of-function variants in a CVID-like B-cell deficiency.
Autosomal recessive inheritance is supported by biallelic PRKCD variants in affected individuals. One consanguineous patient harbored NM_006254.4(PRKCD):c.1182del (p.Met395fs) (PMID:23319571), and an independent WES cohort identified a second unrelated CVID proband with PRKCD LoF (PMID:29867916), totaling 2 probands. No additional segregating relatives have been reported.
Genetic spectrum is characterized by frameshift and splice-site mutations leading to absent or truncated PKCδ protein; the canonical variant c.1182del (p.Met395fs) abolishes catalytic activity. These LoF variants reduce substrate phosphorylation and impair class-switch recombination, consistent with loss-of-function mechanism.
Functional assays in patient-derived B cells demonstrate absent PKCδ expression, decreased MARCKS phosphorylation, resistance to B-cell receptor-mediated apoptosis, and increased IL-6 transcription (PMID:23319571). Rescue of apoptosis by PRKCD reconstitution in patient cell lines further confirms causality (PMID:23430113). Murine PKCδ deficiency recapitulates the B-cell hyperproliferation and hypogammaglobulinemia seen in human CVID.
Collectively, limited genetic evidence from 2 unrelated probands combined with strong functional concordance establishes a Limited ClinGen gene–disease association. Additional case series may strengthen the evidence, but current data support PRKCD testing in early-onset CVID patients.
Key Take-home: AR PRKCD LoF variants underlie a CVID-like syndrome by impairing B-cell apoptosis and antibody production, and should be included in diagnostic gene panels for CVID.
Gene–Disease AssociationLimited2 probands (consanguineous family and WES cohort), no segregation; functional concordance Genetic EvidenceLimitedTwo probands with biallelic LoF variants in PRKCD; did not reach genetic scoring cap Functional EvidenceStrongPatient cell assays show absent PKCδ expression, impaired apoptosis, rescue by reconstitution; mouse model phenocopy |